Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | Pre-commercial biotech companies market capitalization U.S. 2017

Pre-commercial biotech companies with large market caps in the United States 2017

Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data illustrates the market capitalization of pre-commercial biotechnology companies in the U.S. that have reached over one billion USD as of March 2017. At this time, Puma Biotechnology had a market capitalization of 1.38 billion USD.

Alnylam Pharmaceuticals 4410
Kite Pharma 4304
Neurocine Biosciences 3772
bluebird bio 3713
Ultragenyx Pharmaceutical 2828
Sage Therapeutics 2649
Agios Pharmaceuticals 2466
Intrexon 2353
Juno Therapeutics 2353
Portola Pharmaceuticals 2216
AveXis 2109
Radius Health 1669
Spark Therapeutics 1656
FibroGen 1575
Aerie Therapeutics 1525
Blueprint Medicines 1524
Array Biopharma 1511
TherapeuticsMD 1422
Puma Biotechnology 1375
Emergent BioSolutions 1182

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.